Elanco to expand Elwood plant; add new jobs
08/21/2024

(KAIR)--The planned expansion and renovation of an Elwood-based manufacturing facility means the creation of new jobs.

Word of forthcoming Elanco Animal Health Inc. expansion was made Tuesday in a release from Kansas Governor Laura Kelly.

The release explains that Elanco, a global leader in animal health, is investing $130 million for the facility overhaul, which is expected to create around 70 new jobs over the next two years.

The expansion project will help enhance the local economy through increased tax revenue and serve as a stable long-term employer in Elwood, making the company, the release says, "better positioned to optimally serve customer demands with improved project development and commercialization lead times."

Elanco- Elwood site currently manufactures and ships its Canine Parvovirus Monoclonal Antibody-the first and only USDA conditionally approved targeted treatment for parvovirus-and will be the flagship location for the company's antibody manufacturing, with the release noting that the expansion "will add the needed capacity to support Elanco- growth in monoclonal antibody innovation."

Design-build firm Burns & McDonnell, headquartered in Kansas City, is leading the expansion project as the primary provider of integrated design and construction services.


© Many Signals Communications

You will need to be logged in to leave a comment.

Please Login


characters left

The posting of advertisements, profanity, or personal attacks is prohibited.

Click here to review our Terms of Use.